Home › Leukemia › Colorado › Denver
Leukemia clinical trials in Denver, CO
7 studies for Leukemia are looking for participants at sites in and around Denver (within about 30 miles). Open a study to see who can join and how to contact the study team.
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
RecruitingPhase 3
- Research Site, Denver
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RecruitingPhase 1
- Colorado Blood Cancer Institute, Denver
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
RecruitingPhase 3
- Colorado Blood Cancer Institute, Denver
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
RecruitingPhase 2
- Colorado Children's Hospital, Denver
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
RecruitingPhase 1/2
- Colorado Blood Cancer Institute, Denver
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RecruitingPhase 1
- Colorado Blood Cancer Institute, Denver
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Denver
About Leukemia
Leukemia is cancer of the white blood cells. There are two types of Leukemias, acute and chronic. Learn about the differences and treatments available.
More about Leukemia on MedlinePlus
Leukemia trials in other cities
- Houston, TX28 studies
- Boston, MA25 studies
- New York City, NY19 studies
- Chicago, IL16 studies
- Los Angeles, CA16 studies
- Durham, NC13 studies
- Philadelphia, PA12 studies
- Columbus, OH12 studies
- Nashville, TN12 studies
- Baldwin Park, CA12 studies
- Milwaukee, WI11 studies
- Seattle, WA11 studies
Other studies in Denver
- Metastatic Cancer29 studies
- Non-Small Cell Lung Cancer28 studies
- Breast Cancer28 studies
- Multiple Myeloma26 studies
- Colorectal Cancer23 studies
- Cancer (all types)20 studies
- Prostate Cancer19 studies
- Melanoma19 studies
- Ovarian Cancer16 studies
- Endometrial Cancer16 studies
- Lung Cancer16 studies
- Non-Hodgkin Lymphoma14 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.